Annals of Cancer Research and Therapy
Online ISSN : 1880-5469
Print ISSN : 1344-6835
ISSN-L : 1344-6835
Presence of Circadian oscillation of Multidrug Resistance Gene 1 in KB-C2 cell line
Motoki SassaYoshihisa KoyamaMasashi HigashimotoKoichiro OnoNobuhiro YoshimotoTomoyuki MommaMasaru SaitoJin AndoMasaru NodaKotaro MiyamotoYusuke KobayashiHidekazu SugenoTeruhide IshigameShotaro FujitaTesturo ItoWataru SakamotoNoriko AbeManabu IwadateTuneyuki YoshidaTakasi OhshimaYuji TakebayashiSeiichi Takenoshita
Author information
JOURNAL FREE ACCESS

2010 Volume 18 Issue 1 Pages 13-18

Details
Abstract

Many physiological, biochemical and behavioral processes are under circadian regulation, which is generated by an internal time-keeping mechanism referred to as biological clock in almost all organisms from bacteria to mammals. Although the substantial evidences that the circadian clock could modulate the morbidity and efficacy of anticancer therapy have been proposed, underlying mechanisms for chronotherapy has been only poorly elucidated, and it has not been popular in clinic. The aim of this study was to determine the relationship between the expression of P-glycoprotein (P-gp)/MDR1, which is one of the important molecules in anti-cancer drug resistance, and circadian rhythm in KB-C2 cells. The present study demonstrated that both MDR1 expression level and its promoter activity oscillated after treatment with high concentration of fetal bovine serum. Moreover, cytotoxic effect of taxol were dependent on the fluctuated levels of MDR1. These results suggest that the circadian rhythm of MDR1 may have an influential effect on cytotoxicity of anti-cancer drug and could be available for chemotherapy in clinic.

Content from these authors
© 2010 by The Japanese Society of Strategies for Cancer Research and Therapy
Previous article Next article
feedback
Top